Erratum: Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model (Proceedings of the National Academy of Sciences of the United States of America (2013) 110 (6853-6858) (DOI:10.1073/pnas.1216436110));Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 17, 2013, Pages 6853-6858

  Danielsson, Frida ^a   Skogs, Marie ^a   Huss, Mikael ^b   Rexhepaj, Elton ^a   O'Hurley, Gillian ^c   Klevebring, Daniel ^a,d   Pontén, Fredrik ^c   Gad, Annica K B ^d   Uhlén, Mathias ^a   Lundberg, Emma ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

3 HYDROXYBUTYRATE DEHYDROGENASE TYPE 1 GENE; ALDEHYDE DEHYDROGENASE 1 GENE; ALPHA SMOOTH MUSCLE ACTIN GENE; ANILLIN GENE; ANNEXIN A1 GENE; APOPTOSIS; ARTICLE; BUB1B GENE; CARCINOGENESIS; CDC25A GENE; CDC7 GENE; CDCA7 GENE; CELL ADHESION; CELL CYCLE PROGRESSION; CELL DEDIFFERENTIATION; CELL FUNCTION; CELL IMMORTALIZATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CELL TRANSFORMATION; COLON CARCINOGENESIS; DHFR GENE; DOWN REGULATION; EEF1A2 GENE; EPIREGULIN GENE; ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1 LIKE 3 GENE; FANCG GENE; FIBROBLAST ACTIVATION PROTEIN GENE; FOLLOW UP; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; MALIGNANT TRANSFORMATION; MCM2 GENE; MCM3 GENE; METASTASIS; MYBL1 GENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN SECRETION; RNA SEQUENCE; TP53 GENE; TRANSCRIPTOMICS;

EID: 84876846983     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1522746112     Document Type: Erratum

References (37)

1. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61(5):759-767.
2. Land H, Parada LF, Weinberg RA (1983) Cellular oncogenes and multistep carcino-genesis. Science 222(4625):771-778.
3. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57-70.
4. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: The next generation. Cell 144(5):646-674.
5. Cancer Genome Atlas Research Network (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474(7353):609-615.
6. Uhlen M, et al. (2010) Towards a knowledge-based Human Protein Atlas. Nat Bio-technol 28(12):1248-1250.
7. MacKenzie KL, et al. (2002) Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras. Oncogene 21(27):4200-4211.
8. Land H, Parada LF, Weinberg RA (1983) Tumorigenic conversion of primary embryo fi-broblasts requires at least two cooperating oncogenes. Nature 304(5927):596-602.
9. Hahn WC, et al. (1999) Creation of human tumour cells with defined genetic elements. Nature 400(6743):464-468.
10. Kim NW, et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266(5193):2011-2015.
11. Chang B, et al. (2009) ALDH1 expression correlates with favorable prognosis in ovarian cancers. Mod Pathol 22(6):817-823.
12. Kahlert C, et al. (2011) Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. BMC Cancer 11:275.
13. Charafe-Jauffret E, et al. (2010) Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 16(1):45-55.
14. Khoury T, et al. (2012) Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy. Mod Pathol 25(3):388-397.
15. Toyoda H, Komurasaki T, Uchida D, Morimoto S (1997) Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem J 326(Pt 1):69-75.
16. Ahuja D, Sáenz-Robles MT, Pipas JM (2005) SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24(52):7729-7745.
17. Rozan LM, El-Deiry WS (2007) p53 downstream target genes and tumor suppression: A classical view in evolution. Cell Death Differ 14(1):3-9.
18. Ketolainen JM, Alarmo EL, Tuominen VJ, Kallioniemi A (2010) Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4. Breast Cancer Res Treat 124(2):377-386.
19. Farnsworth RH, et al. (2011) A role for bone morphogenetic protein-4 in lymph node vascular remodeling and primary tumor growth. Cancer Res 71(20):6547-6557.
20. Madhyastha H, Madhyastha R, Nakajima Y, Omura S, Maruyama M (2012) Regulation of growth factors-associated cell migration by C-phycocyanin scaffold in dermal wound healing. Clin Exp Pharmacol Physiol 39(1):13-19.
21. Park S, Kim ES, Noh DY, Hwang KT, Moon A (2011) H-Ras-specific upregulation of granulocyte colony-stimulating factor promotes human breast cell invasion via matrix metalloproteinase-2. Cytokine 55(1):126-133.
22. Hall PA, et al. (2005) The septin-binding protein anillin is overexpressed in diverse human tumors. Clin Cancer Res 11(19 Pt 1):6780-6786.
23. Suzuki C, et al. (2005) ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway. Cancer Res 65(24):11314-11325.
24. Nomura H, et al. (2009) Down-regulation of plasma membranous Annexin A1 protein expression in premalignant and malignant lesions of the oral cavity: Correlation with epithelial differentiation. J Cancer Res Clin Oncol 135(7):943-949.
25. Lin CY, et al. (2008) Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma. J Surg Oncol 97(6):544-550.
26. Krupkova O, Jr., Loja T, Zambo I, Veselska R (2010) Nestin expression in human tumors and tumor cell lines. Neoplasma 57(4):291-298.
27. Nowak MA, et al. (2002) The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci USA 99(25):16226-16231.
28. Maki RG (2010) Small is beautiful: Insulin-like growth factors and their role in growth, development, and cancer. J Clin Oncol 28(33):4985-4995.
29. Su Y, et al. (2011) Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene 30(37):3907-3917.
30. Vizioli MG, et al. (2010) IGFBP7: An oncosuppressor gene in thyroid carcinogenesis. Oncogene 29(26):3835-3844.
31. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR (2008) Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132(3):363-374.
32. Cao Y, et al. (2008) Loss of annexin A1 expression in breast cancer progression. Appl Immunohistochem Mol Morphol 16(6):530-534.
33. Maschler S, et al. (2010) Annexin A1 attenuates EMT and metastatic potential in breast cancer. EMBO Mol Med 2(10):401-414.
34. Gao D, Vahdat LT, Wong S, Chang JC, Mittal V (2012) Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res 72(19):4883-4889.
35. Pütz SM, Vogiatzi F, Stiewe T, Sickmann A (2010) Malignant transformation in a defined genetic background: Proteome changes displayed by 2D-PAGE. Mol Cancer 9:254.
36. Fagerberg L, et al. (2011) Mapping the subcellular protein distribution in three human cell lines. J Proteome Res 10(8):3766-3777.
37. Kampf C, Olsson I, Ryberg U, Sjostedt E, Ponten F (2012) Production of tissue micro-arrays, immunohistochemistry staining and digitalization within the Human Protein Atlas. J Vis Exp (63):pii 3620.